info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Antibody Drug Conjugate Companies

Antibody Drug Conjugate companies focus on the development of innovative cancer treatments. They specialize in combining monoclonal antibodies with potent drugs, creating targeted therapies that deliver medication directly to cancer cells. These companies contribute to advancing precision medicine in oncology.

Antibody Drug Conjugate Key Companies

 

Latest Antibody Drug Conjugate Companies Update


Pfizer's $43 Billion Seagen Acquisition This mega-deal closed in March 2023, solidifying Pfizer's position as a leading ADC player. It signifies the immense potential and projected value of the market.


Merck & Daiichi Sankyo Join Forces A $22 billion collaboration inked in December 2023 will see the development and commercialization of three promising ADC candidates. This partnership highlights the importance of strategic alliances in advancing ADC research.


Next-Gen Linkers for Enhanced Targeting Companies like ImmunoGen are developing novel linker technologies to improve ADC stability and delivery to targeted cancer cells.


List of Antibody Drug Conjugate Key Companies in the Market



  • ADC Therapeutics

  • Takeda Pharmaceutical Company Ltd.

  • GlaxoSmithKline Plc

  • Hoffmann-La Roche Ltd.

  • Daiichi Sankyo Company Ltd.

  • Pfizer Inc.

  • Seagen Inc.

  • Gilead Sciences Inc.

  • Astellas Pharma


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.